References
- AalbersRAyresJBackerVFormoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trialEur Respir J2002199364312030736
- ACCP/AACVPR Pulmonary Rehabilitation Guidelines PanelACCP/AACVPR Pulmonary Rehabilitation GuidelinesChest19971121363969367481
- CasaburiRKukafkaDCooperCBImprovement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest20051278091715764761
- CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921724.11866001
- CelliBRMacNeeWATS/ERS Task Force Committee MembersStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J2004239324615219010
- CelliBZuWallackRWangSImprovements in resting inspiratory capacity and hyperinflation with tiotropium in COPD with increased static lung volumesChest20031241743814605043
- [GOLD] Global Initiative for Chronic Obstructive Lung DiseaseNHLBI/WHO Workshop Report [online]2005 2001, Update 2005. Accessed November 10, 2005. URL: http://www.goldcopd.com
- GuyattGHBermanLBTownsendMA measure of quality of life for clinical trials in chronic lung diseaseThorax19874277383321537
- JonesPWQuirkFHBaveystockCMA self-complete measure of health status for chronic airflow limitationAm Rev Respir Dis1992145132171595997
- MahlerDAWeinbergDHWellsCKBaseline dyspnoea index and transitional dyspnoea index: The measurement of dyspnoeaChest19848575186723384
- MaltaisFHamiltonAMarciniukDImprovements in symptom-limited exercise performance over eight hours with once-daily tiotropium in patients with COPDChest200512811687816162703
- MorrisJFKoskiATempleWPFifteen year interval spirometric evaluation of the Oregon predictive equationsChest19889312373335142
- O’DonnellDFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J2004a2383240
- O’DonnellDEVoducNFitzpatrickMEffect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary diseaseEur Respir J2004b248694
- RennardSIAndersonWZuwallackRUse of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116310879211316640
- WeaverTENarsavageGLPhysiological and psychological variables related to functional status in chronic obstructive pulmonary diseaseNurs Res199241286911523109